| Financial Year |
March 31 2023 |
| Monetary Funds |
1,523,647,274.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
213,266,408.90 |
| Accounts Receivable |
1,193,097,909.70 |
| Advances to Suppliers |
35,304,636.70 |
| Other Receivables |
8,601,893.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,000,000.00 |
| Inventories |
1,030,706,443.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,522,503.70 |
| Total Current Assets |
4,483,612,425.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
132,431,060.75 |
| Investment Properties |
-- |
| Fixed Assetes |
1,255,627,424.93 |
| Under-construction Projects |
92,219,025.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
162,954,403.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
949,477.07 |
| Deferred Income Tax Assets |
58,525,981.32 |
| Other Non-Current Assets |
23,968,060.80 |
| Sub-Total of Non-Current Assets |
1,851,903,462.74 |
| Total Assets |
6,335,515,887.95 |
| Short-Term Loans |
77,963,023.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
106,915,466.20 |
| Accounts Payable |
1,500,484,851.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
83,942,426.77 |
| Taxes Payable |
46,749,815.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,549,126.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
93,838,634.16 |
| Other Current Liabilities |
68,737,295.05 |
| Sub-Total of Current Liabilities |
2,054,152,672.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,827,827.22 |
| Deferred Income Tax Liabilities |
87,277,022.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
235,402,997.21 |
| Total Liabilities |
2,289,555,669.88 |
| Paid-In Capital(Or Share Stock) |
512,634,266.00 |
| Capital Surplus |
778,888,510.03 |
| Surplus Reserve |
332,426,507.04 |
| LESS:Treasury Stock |
9,528,927.12 |
| Undistributed Profits |
2,337,465,976.78 |
| Minority Stockholder's Interest |
139,530,620.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,906,429,597.37 |
| Owner's Equity（Stockholder's Equity） |
4,045,960,218.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,335,515,887.95 |
